ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2020
Confirmation of
Registry-linked trialAbstract read
In one paragraph
Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01453127 (DaTSCAN Imaging in Aging and Neurodegenerative Disease), which is not on this map. Cited by 22 papers, 3 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 3 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
DaTSCAN Imaging in Aging and Neurodegenerative Disease
Who cites it
22 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Diagnostic performance of molecular imaging methods in predicting the progression from mild cognitive impairment to dementia: an updated systematic review.European journal of nuclear medicine and molecular imaging · 2024Pooled it
- Research diagnostic criteria for mild cognitive impairment with Lewy bodies: A systematic review and meta-analysis.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023Pooled it
- The diagnostic performance of functional dopaminergic scintigraphic imaging in the diagnosis of dementia with Lewy bodies: an updated systematic review.European journal of nuclear medicine and molecular imaging · 2023Pooled it
- Presynaptic dopaminergic imaging as a neurodegeneration staging biomarker in the alpha-synucleinopathy continuum.European journal of nuclear medicine and molecular imaging · 2026Article
- Discordance Between Striatal Dopaminergic Imaging and Motor Performances in REM Sleep Behavior Disorder.Neurology open access · 2026Article
- Skin Biopsy for Phosphorylated α-Synuclein in Mild Cognitive Impairment or Dementia Due to Lewy Body Disease in a Convenience Cohort from a Subspecialty Behavioral Neurology Practice.Movement disorders : official journal of the Movement Disorder Society · 2026Article
- Heterogeneity of dementia with lewy bodies: Insights from clinical presentations, neuropathology, and biomarkers.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025Review
- Magnetic susceptibility components reveal different aspects of neurodegeneration in alpha-synucleinopathies.Scientific reports · 2025Article
- Prominent loss of striatal dopamine transporter binding in frontotemporal lobar degeneration with the MAPT N279K mutation present as early as at prodromal stage without parkinsonism.Parkinsonism & related disorders · 2024Article
- Neuroimaging biomarkers in the biological definition of Parkinson's disease and dementia with Lewy bodies - EANM position on current state, unmet needs and future perspectives.European journal of nuclear medicine and molecular imaging · 2024Article
- Presynaptic Dopaminergic Imaging Characterizes Patients with REM Sleep Behavior Disorder Due to Synucleinopathy.Annals of neurology · 2024Article
- Metabolic network alterations as a supportive biomarker in dementia with Lewy bodies with preserved dopamine transmission.European journal of nuclear medicine and molecular imaging · 2024Article
- Article
- Different z-score cut-offs for striatal binding ratio (SBR) of DaT SPECT are needed to support the diagnosis of Parkinson's Disease (PD) and dementia with Lewy bodies (DLB).European journal of nuclear medicine and molecular imaging · 2023Article
- Brain glucose metabolism and nigrostriatal degeneration in isolated rapid eye movement sleep behaviour disorder.Brain communications · 2023Article
- Generative adversarial network-based attenuation correction forFrontiers in medicine · 2023Article
- Imaging tau burden in dementia with Lewy bodies using [Neurobiology of aging · 2021Article
- The value of multimodal imaging withNeurobiology of aging · 2021Article
- Dopaminergic imaging and clinical predictors for phenoconversion of REM sleep behaviour disorder.Brain : a journal of neurology · 2021Article
- Recent Developments in Positron Emission Tomography Tracers for Proteinopathies Imaging in Dementia.Frontiers in aging neuroscience · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Daniela D MaltaisDepartment of Radiology, Mayo Clinic, Rochester, Minnesota.
Lennon G JordanDepartment of Radiology, Mayo Clinic, Rochester, Minnesota.
Hoon-Ki MinDepartment of Radiology, Mayo Clinic, Rochester, Minnesota.
Toji MiyagawaDepartment of Neurology, Mayo Clinic, Rochester, Minnesota.
Scott A PrzybelskiDepartment of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
Timothy G LesnickDepartment of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
Robert R ReichardDepartment of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota; and.
Dennis W DicksonDepartment of Neuroscience, Mayo Clinic, Jacksonville, Florida.
Melissa E MurrayDepartment of Neuroscience, Mayo Clinic, Jacksonville, Florida.
Kejal KantarciDepartment of Radiology, Mayo Clinic, Rochester, Minnesota.
Bradley F BoeveDepartment of Neurology, Mayo Clinic, Rochester, Minnesota.
Val J LoweDepartment of Radiology, Mayo Clinic, Rochester, Minnesota vlowe@mayo.edu.
Funding
THE PGRN/TDP-43 AXIS IN ALZHEIMER?S DISEASE AND NEURODEGENERATIONP50AG016574 · NIA · MAYO CLINIC ROCHESTER · PI PETERSEN, RONALD C · 1999 to 2018
$36.9MResearch Education ComponentP30AG062677 · NIA · MAYO CLINIC ROCHESTER · PI DENNIS WILLIAM DICKSON · 2019 to 2026
$33.5MLongitudinal Imaging Biomarkers of Prodromal DLBU01NS100620 · NINDS · MAYO CLINIC ROCHESTER · PI Bradley F Boeve, KEJAL KANTARCI · 2017 to 2026
$19.2MTRAINING IN TRANSLATIONAL RESEARCH: BENCH TO BEDSIDER25GM055252 · NIGMS · MAYO CLINIC ROCHESTER · PI LUJAN, LUIS, MAHER, LOUIS JAMES · 1996 to 2022
$8.3MMayo Clinic Interdisciplinary Women's Health Research ProgramK12HD065987 · NICHD · MAYO CLINIC ROCHESTER · PI KANTARCI, KEJAL · 2010 to 2023
$6.7MPost-baccalaureate Training in Biomedical ResearchR25GM075148 · NIGMS · MAYO CLINIC ROCHESTER · PI LUJAN, LUIS, MAHER, LOUIS JAMES · 2006 to 2024
$6.1MNIA NIH HHS P30 AG062677NIA NIH HHS P50 AG016574NICHD NIH HHS K12 HD065987NIGMS NIH HHS R25 GM055252NIGMS NIH HHS R25 GM075148NINDS NIH HHS U01 NS100620
Abstract
Our rationale was to conduct a retrospective study comparing 3
Indexed as
Iodine RadioisotopesTropanesAgedAged, 80 and overAlzheimer DiseaseCorpus StriatumFemaleHumansLewy Body DiseaseMaleMiddle AgedParkinson DiseaseRetrospective StudiesTomography, Emission-Computed, Single-Photon2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropaneIodine RadioisotopesTropanes123I-FP-CIT SPECT123I-ioflupanedementia with Lewy bodiesLewy body diseaseneuropathology
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
NCT01453127ClinicalTrials.gov
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.